EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

dc.contributor.author	Guzelant, Gul
dc.contributor.author	Ucar, Didar
dc.contributor.author	Guzelant, Gul
dc.contributor.author	Hamuryudan, Vedat
dc.contributor.author	Esatoglu, Sinem Nihal
dc.contributor.author	Hatemi, Gulen
dc.contributor.author	Seyahi, Emire
dc.contributor.author	Yurdakul, Sebahattin
dc.contributor.author	Ozyazgan, Yilmaz
dc.contributor.author	Yazici, Hasan
dc.date.accessioned	2021-03-03T17:18:30Z
dc.date.available	2021-03-03T17:18:30Z
dc.identifier.citation	Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N. , Yurdakul S., Seyahi E., Yazici H., Hamuryudan V., "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME", 18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94
dc.identifier.other	vv_1032021
dc.identifier.other	av_491df173-77d2-4c7a-b202-bfe34506257e
dc.identifier.uri	http://hdl.handle.net/20.500.12627/52596
dc.language.iso	eng
dc.subject	İç Hastalıkları
dc.subject	Sağlık Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ROMATOLOJİ
dc.subject	İmmünoloji ve Romatoloji
dc.subject	Dahili Tıp Bilimleri
dc.title	EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME
dc.type	Bildiri
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	56
dc.contributor.firstauthorID	151281

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.